Anonymous
Guest
Anonymous
Guest
The elephant in the room here is that MRK stock is not just Merck. It is Schering and, to a lesser extent, Lebanon as well. Schering merged with Organon just before it was poised to go public and not long before Merck bought them out.
If you consider Legacy Merck's pre- merger stock price, Legacy Shering's pre- merger stock price and the estimated IPO price Organon may have commanded, you'll see that any portion at all from L-SP and Organon's valuation has been effectively removed from the current MRK price - AND MRK has also declined in value. Think about that. ALL of the market value of two other large-scale, multinational companies has gone to ZERO within 2-4 years.
As an optimist I guess you could say that all the money that will be gone is but I don't think you can do it with a straight face.
If you consider Legacy Merck's pre- merger stock price, Legacy Shering's pre- merger stock price and the estimated IPO price Organon may have commanded, you'll see that any portion at all from L-SP and Organon's valuation has been effectively removed from the current MRK price - AND MRK has also declined in value. Think about that. ALL of the market value of two other large-scale, multinational companies has gone to ZERO within 2-4 years.
As an optimist I guess you could say that all the money that will be gone is but I don't think you can do it with a straight face.